European Commission Approves Purchase Agreement for 200 Million J&J Covid-19 Vaccine Doses
October 08 2020 - 8:35AM
Dow Jones News
By Dave Sebastian
Johnson & Johnson said the European Commission has approved
an advance purchase agreement for 200 million doses of its Covid-19
vaccine candidate following authorization from regulators.
European Union member states will also have the option to get up
to 200 million additional doses, J&J said Thursday.
The company said it has also allocated up to 500 million doses
toward international efforts to ensure access to lower income
countries, with delivery beginning in mid-2021 after regulatory
approval.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
October 08, 2020 08:20 ET (12:20 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024
